CRM
BLFS icon

Cramer Rosenthal McGlynn’s BioLife Solutions BLFS Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
+632,812
New +$14M 0.89% 41
2025
Q4 		– Sell
-96,590
Closed -$2.46M – 89
2025
Q3 		$2.46M Sell
96,590
-607,565
-86% -$14.4M 0.16% 90
2025
Q2 		$15.2M Buy
704,155
+19,770
+3% +$446K 1.04% 39
2025
Q1 		$15.6M Sell
684,385
-221,367
-24% -$5.83M 1.13% 39
2024
Q4 		$23.5M Sell
905,752
-196,907
-18% -$4.9M 1.33% 30
2024
Q3 		$27.6M Sell
1,102,659
-198,170
-15% -$4.68M 1.53% 27
2024
Q2 		$27.9M Buy
1,300,829
+133,601
+11% +$2.59M 1.64% 19
2024
Q1 		$21.7M Buy
+1,167,228
New +$20.4M 1.18% 38

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return